Evidence map›Paper›PMID 33491337›Full record

ArticleInfluenza and other respiratory viruses2021

Epidemiology and seasonality of human parainfluenza serotypes 1-3 in Australian children.

Daniel R L Greiff, Alice Patterson-Robert, Christopher C Blyth, Kathryn Glass, Hannah C Moore

Abstract read
In one paragraph

Article in Influenza and other respiratory viruses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Daniel R L GreiffWesfarmers Centre for Vaccine and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, WA, Australia.ORCID 0000-0002-1453-9846
Alice Patterson-RobertMedical School, College of Health and Medicine, Australian National University, Canberra, ACT, Australia.
Christopher C BlythWesfarmers Centre for Vaccine and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, WA, Australia.ORCID 0000-0003-2017-0683
Kathryn GlassResearch School of Population Health, Australian National University, Canberra, ACT, Australia.ORCID 0000-0001-5905-1310
Hannah C MooreWesfarmers Centre for Vaccine and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, WA, Australia.ORCID 0000-0001-6434-8290

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundParainfluenza viruses are significant contributors to childhood respiratory illness worldwide, although detailed epidemiological studies are lacking. Few recent Australian studies have investigated serotype-specific PIV epidemiology, and there is a paucity of southern hemisphere PIV reports. We report age-stratified PIV hospitalisation rates and a mathematical model of PIV seasonality and dynamics in Western Australia (WA).

methodsWe used linked perinatal, hospital admission and laboratory diagnostic data of 469 589 children born in WA between 1996 and 2012. Age-specific rates of viral testing and PIV detection in hospitalised children were determined using person time-at-risk analysis. PIV seasonality was modelled using a compartmental SEIRS model and complex demodulation methods.

resultsFrom 2000 to 2012, 9% (n = 43 627) of hospitalised children underwent PIV testing, of which 5% (n = 2218) were positive for PIV-1, 2 or 3. The highest incidence was in children aged 1-5 months (PIV-1:62.6 per 100 000 child-years, PIV-2:26.3/100 000, PIV-3:256/100 000), and hospitalisation rates were three times higher for Aboriginal children compared with non-Aboriginal children overall (IRR: 2.93). PIV-1 peaked in the autumn of even-numbered years, and PIV-3 annually in the spring, whereas PIV-2 had inconsistent peak timing. Fitting models to the higher incidence serotypes estimated reproduction numbers of 1.24 (PIV-1) and 1.72 (PIV-3).

conclusionPIV-1 and 3 are significant contributors towards infant respiratory hospitalisations. Interventions should prioritise children in the first 6 months of life, with respect to the observed autumn PIV-1 and spring PIV-3 activity peaks. Continued surveillance of all serotypes and investigation into PIV-1 and 3 interventions should be prioritised.

Indexed as

Paramyxoviridae InfectionsRespiratory Tract InfectionsAustraliaChildFemaleHospitalizationHumansInfantPregnancySeasonsSerogroupdata linkagehospitalisationincidenceinfantsparainfluenza virusesseasonality

Identifiers

PMID33491337
PMCPMC8404051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.